UPDATE : Wednesday, February 20, 2019
상단여백
Medicine exports increase thanks to brisk shipments to US
Korea’s cumulative export of medicine and medical suppliers (HS code: 3003,...
by Nam Doo-hyun  |  2018-12-24 15:27
라인
Hyundai Pharm to develop combo drug for diabetes + hypertension
Hyundai Pharmaceutical has started to develop a combination treatment, whic...
by Lee Hye-seon  |  2018-12-24 10:56
라인
Consumer healthcare giant born out of GSK-Pfizer tie-up
Multinational drugmakers GSK and Pfizer said they would merge consumer heal...
by Nam Doo-hyun  |  2018-12-20 14:40
라인
Local firms rush to develop blinding disease treatments
The macular degeneration treatment market is heating up with local drugmake...
by Nam Doo-hyun  |  2018-12-20 14:37
라인
Astellas Korea rebuked for arbitrarily modifying trials
Astellas Korea received administrative punishment for changing details of t...
by Lee Hye-seon  |  2018-12-20 11:05
라인
Daewoong to export BTX product to 3 countries
Daewoong Pharmaceutical said Thursday that it has signed an export agreemen...
by Lee Han-soo  |  2018-12-20 10:40
라인
Hanmi’s lung cancer drug fails to win breakthrough therapy designation
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Thursday that Poziotini...
by Lee Han-soo  |  2018-12-20 10:40
라인
Bridge Bio, Daewoong to co-develop ulcerative colitis drug candidate
Bridge Biotherapeutics said Wednesday that the company has signed a license...
by Lee Han-soo  |  2018-12-20 10:39
라인
Beta-cell preservation key for Korean diabetes patients
An expert has claimed that beta cell preservation is essential for the mana...
by Lee Han-soo  |  2018-12-19 15:55
라인
Drugmaker booked for bribing doctors with propofol discounts
The police caught a pharmaceutical firm bribing physicians by selling anest...
by Lee Hye-seon  |  2018-12-19 14:12
라인
Handok to test new insomnia drug in phase-3 study
Handok said it would conduct a global phase-3 clinical trial to test Nemore...
by Lee Hye-seon  |  2018-12-19 11:44
라인
Bridge Biotherapeutics announces FDA Clearance for idiopathic pulmonary fibrosis treatment
Bridge Biotherapeutics said Monday that the U.S. Food and Drug Administrati...
by Lee Han-soo  |  2018-12-19 10:25
라인
Korea’s botulinum toxin exports rebound in November
Exports of botulinum toxin products, which had declined for several months,...
by Nam Doo-hyun  |  2018-12-18 15:51
라인
Will healthcare meetings restore investor confidence in pharmaceuticals?
Industry officials are looking what kind of positive issues will boost inve...
by Nam Doo-hyun  |  2018-12-17 15:44
라인
Shinpoong’s drug becomes first-line malaria treatment in Côte d'Ivoire
Korean drugmaker Shinpoong Pharm said Côte d'Ivoire listed the co...
by Park Gi-taek  |  2018-12-17 14:20
라인
Sanofi launches five P3 clinical trials for Hanmi’s diabetic drug
Hanmi Pharmaceutical said Friday that Sanofi, its global partner for efpegl...
by Lee Han-soo  |  2018-12-14 15:17
라인
New hepatitis C drugs compete in shrinking market
Despite the shrinking size of the hepatitis C treatment market with more pa...
by Nam Doo-hyun  |  2018-12-14 15:14
라인
Yuyu unveils new osteoporosis treatment
Yuyu Pharmaceutical said Thursday that it has launched Bazestar, a compound...
by Lee Han-soo  |  2018-12-13 11:50
라인
SK, Sanofi begins P1 clinical trials for next-gen pneumococcal vaccine
SK Bioscience and Sanofi have started to conduct the U.S. phase 1 clinical ...
by Lee Han-soo  |  2018-12-12 17:22
라인
Dong-A ST, Eugene Bell Foundation to supply tuberculosis drug to NK
Dong-A ST said Wednesday that it has signed sponsorship agreement with Euge...
by Lee Han-soo  |  2018-12-12 17:20
여백
여백
여백
Back to Top